TuHURA Biosciences, Inc./NV Quarterly Debt-to-equity in % from Q1 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TuHURA Biosciences, Inc./NV quarterly Debt-to-equity history and growth rate from Q1 2013 to Q3 2024.
  • TuHURA Biosciences, Inc./NV Debt-to-equity for the quarter ending September 30, 2024 was 75.5 %, a 47.3% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 75.5 -67.8 -47.3% Sep 30, 2024
Q2 2024 127 +63.9 +101% Jun 30, 2024
Q1 2024 231 +187 +425% Mar 31, 2024
Q4 2023 505 +466 +1205% Dec 31, 2023
Q3 2023 143 +110 +336% Sep 30, 2023
Q2 2023 63.3 +36.9 +140% Jun 30, 2023
Q1 2023 44.1 +19.4 +78.2% Mar 31, 2023
Q4 2022 38.7 +17.9 +85.8% Dec 31, 2022
Q3 2022 32.9 +14.3 +77.2% Sep 30, 2022
Q2 2022 26.4 +9.14 +53% Jun 30, 2022
Q1 2022 24.7 +4.76 +23.8% Mar 31, 2022
Q4 2021 20.8 -1.81 -7.99% Dec 31, 2021
Q3 2021 18.6 -6.95 -27.2% Sep 30, 2021
Q2 2021 17.2 -21.7 -55.7% Jun 30, 2021
Q1 2021 20 -12 -37.5% Mar 31, 2021
Q4 2020 22.6 -13.2 -36.8% Dec 31, 2020
Q3 2020 25.5 -19.6 -43.4% Sep 30, 2020
Q2 2020 39 -19.1 -33% Jun 30, 2020
Q1 2020 32 -7.5 -19% Mar 31, 2020
Q4 2019 35.8 +5.07 +16.5% Dec 31, 2019
Q3 2019 45.1 +19.1 +73.2% Sep 30, 2019
Q2 2019 58.1 +37.5 +182% Jun 30, 2019
Q1 2019 39.5 +20.3 +106% Mar 31, 2019
Q4 2018 30.7 +10.5 +52.1% Dec 31, 2018
Q3 2018 26.1 +5.29 +25.5% Sep 30, 2018
Q2 2018 20.6 -9.82 -32.3% Jun 30, 2018
Q1 2018 19.2 -16.7 -46.5% Mar 31, 2018
Q4 2017 20.2 -28.7 -58.7% Dec 31, 2017
Q3 2017 20.8 -57.7 -73.5% Sep 30, 2017
Q2 2017 30.4 -207 -87.2% Jun 30, 2017
Q1 2017 35.8 +605 Mar 31, 2017
Q4 2016 48.9 +499K Dec 31, 2016
Q3 2016 78.4 -490 -86.2% Sep 30, 2016
Q2 2016 237 -149 -38.6% Jun 30, 2016
Q1 2016 -569 -1.05K -218% Mar 31, 2016
Q4 2015 -499K -497K -35939% Dec 31, 2015
Q3 2015 568 +1.08K Sep 30, 2015
Q2 2015 387 +850 Jun 30, 2015
Q1 2015 483 +670 Mar 31, 2015
Q4 2014 -1.38K -1.17K -535% Dec 31, 2014
Q3 2014 -513 -324 -171% Sep 30, 2014
Q2 2014 -463 -306 -194% Jun 30, 2014
Q1 2014 -187 +147 +43.9% Mar 31, 2014
Q4 2013 -218 Dec 31, 2013
Q3 2013 -189 Sep 30, 2013
Q2 2013 -157 Jun 30, 2013
Q1 2013 -334 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.